Equity
€160,138 ▼ 36.5%
ASAPHARM paid out €231,910 in dividends. That is 166% of the 2025 profit.
ASAPHARM
Lifetime
10 annual accounts with figures on one time axispeak €97,106 (2025)
€97,106▲ 75.7%
lowest -€7,166 (2022)
€139,678▲ 14.4%
peak €252,370 (2024)
€160,138▼ 36.5%
€1.7m▲ 61.9%
peak 0 FTE (2024)
0 FTE
Board1 name since 2021
1 director
Documentsfilings and deeds
29-06-202632 days before the deadline
2025abbreviated format
Gross margin from €55,265 to €97,106Dividend €231,910Equity from €252,370 to €160,138Debts from €1.1m to €1.7mInvestments €611,256Cash from €65,868 to €6,694
Key points
from the 2025 annual accountsTurnover
≈ €470,000 estimated
The accounts state no turnover.
Debts
€1.7m 91% of the balance sheet
Financial debts 68%Suppliers 0%Taxes and wages 1%Other 31%
Of this, €534,729 falls due within a year.
Investments
€18,320 1.6 × depreciation
Green is investment, beige is depreciation.
Filings
10 annual accounts 2 late
The 2019 accounts came latest: 45 days after the end of the period.
Position in the sector
8.6%
Lower solvency than 82% of companies in retail trade. Sector median 36.9% · 13,234 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0645733354
Registered office moved from Meux to Grand-Leez
New registered office: Rue de Petit-Leez 42-5031 Grand-Leez · Previous registered office: Rue Saint Sauveur 4, 5081 Meux · General meeting of 21-12-2022 · Gazette deed
Appointment: (director)
Permanent representative: · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 10-03-2022 · Gazette deed
Reappointment: (director)
Permanent representative: · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ASAPHARM Gembloux | €1.9m | €97,106 | 8.6% | 0 |
| VERBIFARMA Pittem | €1.5m | €91,983 | 31.4% | 0 |
| SikaCare Hasselt | €1.8m | €125,616 | 34.2% | 0 |
| DIEUSAERT PHARMA Heuvelland | €1.4m | €114,364 | 36.8% | 0 |
| SAARBACH DINO Chaudfontaine | €1.4m | €74,530 | 78.0% | 0 |
| DEGROFARM Deinze | €1.5m | €113,527 | 10.2% | 0 |
| Duchi-Naert Harelbeke | €1.5m | €156,005 | 38.2% | 0 |
These companies have the same main activity as ASAPHARM: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.4m and €1.8m, founded between 2012 and 2019.
Official details
Source: KBO- Status
- Active since 08-01-2016Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Establishment unit
- 2.249.679.6265031 Gembloux, since 08-01-2016
- Financial year end
- 31 December
- Peppol
- Reachable since 12-09-2025
Annual accounts 2025
- €1.9m▲ 42.8%
- Filing
- Filed on 29-06-2026, 32 days before the end of the filing period
Insights on ASAPHARM
ASAPHARM files the abbreviated format. That format states no turnover. The gross margin rose from €28,071 in 2016 to €97,106 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ASAPHARM
- What is the company number of ASAPHARM?
- The company number of ASAPHARM is 0645.733.354. The VAT number is the same number with BE in front: BE 0645.733.354.
- Where is ASAPHARM based?
- The registered office is at Rue du Petit-Leez, Gd-L. 42, 5031 Gembloux.Company details
- What does ASAPHARM do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of ASAPHARM?
- ASAPHARM is a private limited company (BV).
- When was ASAPHARM founded?
- ASAPHARM was founded on 08-01-2016.
- Is ASAPHARM still active?
- Yes, ASAPHARM is an active enterprise in the KBO register.
- What is the turnover of ASAPHARM?
- The turnover in financial year 2025 is ≈ €470,000. This figure is estimated from the gross margin of €97,106 and 74 comparable companies (NACE 477). It probably lies between €240,000 and €680,000.Financials
- Is ASAPHARM profitable?
- In financial year 2025, ASAPHARM made a profit of €139,678.
- Where can I find the annual accounts of ASAPHARM?
- ASAPHARM filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ASAPHARM due?
- ASAPHARM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.